Synlogic gets Ginkgo Bioworks’ help to launch T. rex inspired synthetic biotic for gout
Synlogic, Inc. has announced a new drug candidate for the treatment of gout developed in…
Synlogic, Inc. has announced a new drug candidate for the treatment of gout developed in…
Enrollment has been completed for a study of a regenerative cell therapy investigational product for…
British Columbia-based Aurinia Pharmaceuticals Inc. announced today (July 22) that its voclosporin drug has been…
U.S. biopharma company ZyVersa Therapeutics, Inc., and Larkspur Health Acquisition Corp., a blank-check special purpose…
A biomass to treat a difficult and evasive fungal infection with a high mortality rate…
Until this year, there were no effective treatments for chronic kidney disease. However, the recent…
Update (31/03/2020): AM-Pharma has raised an extra €47M on top of an existing €116M equity…
French researchers have found that the levels of certain immune cells in the blood of…
Many biotech founders and executives look to VC investors for advice and inspiration, but the…
Quanta Dialysis Technologies has raised €43.2M ($48M) to fund the commercial launch of a device…
Update (01/03/2019): Hansa Biopharma (previously named Hansa Medical) has filed an application for marketing authorization for imlifidase with…
Genetic variations in cell surface proteins are able to predict kidney transplant success, shows Austrian research,…